Hormone Replacement Therapy in Bangkok — Physician-Prescribed Protocols

Hormone replacement therapy (HRT) restores hormones that have declined with age, surgery or medical condition — most commonly testosterone in men and estradiol, progesterone and thyroid in women. At Healthi Life, HRT is bioidentical-first, biomarker-driven and prescribed exclusively by Dr. First, a licensed Thai medical doctor, with longevity oversight by Dr. Petch.

When prescribed at physiologic doses, monitored with biomarkers and matched to individual risk, modern HRT has a favourable safety profile. Risk depends on age at initiation, hormone selection, route, dose and personal and family history. At Healthi Life we screen for cardiovascular, oncologic and thrombotic risk before any prescription and re-test on schedule.

Bioidentical hormones are molecularly identical to those the body produces — bioidentical estradiol, progesterone, testosterone, DHEA. They are typically delivered as transdermal creams, patches, pellets, IM injections or oral micronised capsules. At Healthi Life, bioidentical formulations are first-line whenever clinically appropriate.

Every HRT protocol is designed and prescribed by Dr. First, our Chief Medical Officer and a licensed Thai medical doctor. Dr. Petch, our Chief Medical Strategy Officer and an International Board of Lifestyle Medicine certified physician, oversees integration with longevity programs. No hormone is dispensed without an MD prescription on file.

Most guests notice early signals within 2 to 6 weeks — better sleep, mood, energy and libido. Body composition, lean mass, skin and bone-density changes typically appear by 3 to 6 months. Full biomarker stabilisation is usually confirmed at the 12-week re-test, with dose refinement based on response.

At Healthi Life, HRT programs start from ฿35,000 for a complete 12-week initial cycle. The fee includes the physician intake consultation with Dr. First, a comprehensive hormonal panel, InBody scan, prescribed bioidentical hormones, a scheduled mid-protocol review and an end-of-protocol biomarker re-test. Final investment depends on hormone selection and protocol duration.

Yes. Hormone replacement therapy is legally prescribed by licensed Thai medical doctors within the scope of clinical practice. Bioidentical hormones are dispensed through regulated compounding pharmacies. At Healthi Life, every hormone is prescribed only after consultation, biomarker assessment and a written physician protocol.

Yes — many guests run combined longevity protocols. HRT is often layered with peptide therapy, NAD+ IV protocols or stem cell and exosome therapy under physician design. Combinations are always biomarker-monitored and adjusted by Dr. First, with longevity strategy from Dr. Petch.

TRT (testosterone replacement therapy) is one form of HRT, focused specifically on restoring testosterone in men with clinical deficiency. HRT is the broader category — including estradiol, progesterone, thyroid, DHEA and pregnenolone for both men and women. At Healthi Life, TRT is delivered within the same biomarker-driven framework as the full HRT program.

The baseline hormonal panel includes total and free testosterone, SHBG, estradiol, progesterone, DHEA-S, full thyroid (TSH, free T3, free T4, reverse T3, antibodies), cortisol curve, IGF-1 and key metabolic markers. The panel is matched to your symptoms and goals — never a one-size-fits-all order.

Some guests use HRT cyclically, others continuously, others for a defined window. The decision depends on the indication, your biology, and your goals. For andropause and menopause, long-term replacement is common and clinically supported. For adrenal or DHEA support, shorter cycles are often appropriate. Dr. First reviews this with you at every milestone.

When dosed correctly under physician supervision, modern HRT is generally well-tolerated. Possible effects include fluid retention, acne, mood shifts, breast tenderness, changes in lipid panel or blood pressure. Serious effects are rare but possible — which is why every protocol is biomarker-monitored at week 6 and week 12.